人工智能在胰腺癌诊疗领域的应用现状及前景
作者:
通讯作者:
作者单位:

四川大学华西医院 普外科胰腺外科

作者简介:

刘续宝,四川大学华西医院主任医师,主要从事胰腺疾病的基础临床及转化研究方面的研究。

基金项目:


The current status and prospects of artificial intelligence in the diagnosis and treatment of pancreatic cancer
Author:
Affiliation:

Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    人工智能(AI)在胰腺癌的诊疗中展现出巨大潜力,利用深度学习等算法,在医学影像分析、病理切片识别、药物疗效与预后预测以及新药研发等方面发挥着重要作用。尽管AI在应用过程中仍面临数据获取、模型可解释性等挑战,但随着技术的进步和数据共享的推进,AI有望在胰腺癌的早期筛查、个性化治疗和创新药物开发中发挥更大作用,从而改善患者预后。

    Abstract:

    Artificial intelligence (AI) has demonstrated great potential in the diagnosis and treatment of pancreatic cancer. It plays an important role in medical imaging analysis, pathological slide recognition, drug efficacy and prognosis prediction, as well as new drug development by leveraging deep learning algorithms. Despite challenges such as data acquisition and model interpretability, advancements in technology and data sharing are expected to further enhance its role in early screening, personalized treatment, and innovative drug discovery for pancreatic cancer, ultimately improving patient outcomes.

    参考文献
    相似文献
    引证文献
引用本文

张津银,谭清泉,柯能文,刘续宝.人工智能在胰腺癌诊疗领域的应用现状及前景[J].中国普通外科杂志,2025,34(3):418-427.
DOI:10.7659/j. issn.1005-6947.250013

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-01-06
  • 最后修改日期:2025-02-14
  • 录用日期:
  • 在线发布日期: 2025-04-14